Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequential combination therapies for HBeAg-positive chronic hepatitis B: the search continues. | Hepatol Int | 2021 | 33453018 | PubTator, text mining | PubMed |
| Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis. | Sci Rep | 2021 | 33436824 | PubTator, text mining | PubMed |
| Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. | Pharmaceutics | 2021 | 33435273 | PubTator, text mining | PubMed |
| Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting. | Insights Imaging | 2021 | 33432491 | PubTator, text mining | PubMed |
| Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships. | Expert Opin Drug Metab Toxicol | 2021 | 33401943 | PubTator, text mining | PubMed |
| Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes. | Nanotheranostics | 2021 | 33391975 | PubTator, text mining | PubMed |
| SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma. | Mol Diagn Ther | 2021 | 33387348 | PubTator, text mining | PubMed |
| The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantation. | Eur J Clin Pharmacol | 2021 | 33386894 | PubTator, text mining | PubMed |
| Evaluation of the Utility of PXB Chimeric Mice for Predicting Human Liver Partitioning of Hepatic Organic Anion-Transporting Polypeptide Transporter Substrates. | Drug Metab Dispos | 2021 | 33376106 | PubTator, text mining | PubMed |
| Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide. | Drug Metab Dispos | 2021 | 33355210 | PubTator, text mining | PubMed |
| Combining In Vivo Data with In Silico Predictions for Modeling Hepatic Steatosis by Using Stratified Bagging and Conformal Prediction. | Chem Res Toxicol | 2021 | 33347274 | PubTator, text mining | PubMed |
| Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy. | Expert Opin Drug Metab Toxicol | 2021 | 33339463 | PubTator, text mining | PubMed |
| Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P-gp and BCRP. | Br J Clin Pharmacol | 2021 | 33336408 | PubTator, text mining | PubMed |
| Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. | Clin Pharmacol Ther | 2021 | 33270249 | PubTator, text mining | PubMed |
| The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake. | ChemMedChem | 2021 | 33230949 | PubTator, text mining | PubMed |
| Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF-PH inhibitors. | Nephrology (Carlton) | 2021 | 33222343 | PubTator, text mining | PubMed |
| Examination of Physiologically-Based Pharmacokinetic Models of Rosuvastatin. | CPT Pharmacometrics Syst Pharmacol | 2021 | 33220025 | PubTator, text mining | PubMed |
| Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor-β Signaling in Human Endothelial Cells. | J Pharmacol Exp Ther | 2021 | 33168642 | PubTator, text mining | PubMed |
| Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat. | Clin Pharmacol Ther | 2021 | 33141923 | PubTator, text mining | PubMed |
| Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III. | J Pharmacol Exp Ther | 2021 | 33127749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=46